| 11/24/2025 | Zacks Research | Upgrade | Strong Sell ➝ Hold | | |
| 11/7/2025 | JPMorgan Chase & Co. | Lower Target | Overweight ➝ Overweight | $8.50 ➝ $8.00 | |
| 10/31/2025 | The Goldman Sachs Group | Set Target | | $5.25 | |
| 10/30/2025 | UBS Group | Lower Target | Neutral ➝ Neutral | $7.25 ➝ $6.25 | |
| 10/30/2025 | Mizuho | Set Target | | $8.00 | |
| 10/30/2025 | UBS Group | Reiterated Rating | Positive ➝ Positive | | |
| 10/30/2025 | Raymond James Financial | Reiterated Rating | Outperform ➝ Outperform | $8.00 | |
| 10/30/2025 | BMO Capital Markets | Reiterated Rating | Outperform ➝ Outperform | $9.00 | |
| 10/27/2025 | Stephens | Upgrade | Equal Weight ➝ Overweight | $7.50 ➝ $6.25 | |
| 10/24/2025 | Zacks Research | Downgrade | Hold ➝ Strong Sell | | |
| 10/24/2025 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $8.00 ➝ $6.00 | |
| 10/21/2025 | Wells Fargo & Company | Lower Target | Overweight ➝ Overweight | $8.00 ➝ $7.00 | |
| 8/4/2025 | Mizuho | Lower Target | Outperform ➝ Outperform | $11.00 ➝ $9.00 | |
| 8/4/2025 | Guggenheim | Set Target | Buy ➝ Buy | $9.50 ➝ $8.00 | |
| 8/1/2025 | BMO Capital Markets | Lower Target | Outperform ➝ Outperform | $11.00 ➝ $9.00 | |
| 7/31/2025 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $9.00 ➝ $7.50 | |
| 7/31/2025 | Stifel Nicolaus | Lower Target | Hold ➝ Hold | $8.50 ➝ $7.50 | |
| 7/31/2025 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $11.00 ➝ $8.00 | |
| 7/31/2025 | UBS Group | Lower Target | Neutral ➝ Neutral | $8.25 ➝ $7.25 | |
| 7/18/2025 | Wells Fargo & Company | Lower Target | Overweight ➝ Overweight | $9.00 ➝ $8.00 | |
| 6/30/2025 | BTIG Research | Initiated Coverage | Neutral | | |
| 6/3/2025 | The Goldman Sachs Group | Initiated Coverage | Sell | $6.25 | |
| 5/1/2025 | UBS Group | Lower Target | Neutral ➝ Neutral | $8.50 ➝ $8.25 | |
| 4/24/2025 | Stephens | Lower Target | Equal Weight ➝ Equal Weight | $9.00 ➝ $8.50 | |
| 3/13/2025 | Raymond James Financial | Initiated Coverage | Outperform | $10.00 | |
| 2/20/2025 | Morgan Stanley | Boost Target | Equal Weight ➝ Equal Weight | $8.00 ➝ $9.00 | |
| 2/20/2025 | UBS Group | Boost Target | Neutral ➝ Neutral | $8.00 ➝ $8.50 | |
| 1/21/2025 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $9.00 ➝ $8.00 | |
| 1/14/2025 | Stephens | Initiated Coverage | Equal Weight | $8.00 | |
| 1/13/2025 | Stephens | Upgrade | Hold | | |
| 1/6/2025 | Wells Fargo & Company | Lower Target | Overweight ➝ Overweight | $10.00 ➝ $9.00 | |
| 10/31/2024 | UBS Group | Boost Target | Neutral ➝ Neutral | $7.50 ➝ $8.00 | |
| 8/1/2024 | The Goldman Sachs Group | Boost Target | Sell ➝ Sell | $5.00 ➝ $6.00 | |
| 5/3/2024 | JPMorgan Chase & Co. | Upgrade | Neutral ➝ Overweight | $8.50 | |
| 4/22/2024 | Wells Fargo & Company | Lower Target | Overweight ➝ Overweight | $11.00 ➝ $10.00 | |
| 3/19/2024 | Mizuho | Initiated Coverage | Buy | $11.00 | |
| 2/16/2024 | JPMorgan Chase & Co. | Initiated Coverage | Neutral | $9.50 | |
| 2/15/2024 | Robert W. Baird | Boost Target | Outperform ➝ Outperform | $10.00 ➝ $12.00 | |
| 1/10/2024 | Wells Fargo & Company | Initiated Coverage | Overweight | $11.00 | |
| 10/20/2023 | The Goldman Sachs Group | Lower Target | Sell ➝ Sell | $7.00 ➝ $5.00 | |
| 10/13/2023 | Robert W. Baird | Upgrade | Neutral ➝ Outperform | $10.00 | |
| 9/22/2023 | Guggenheim | Reiterated Rating | Buy ➝ Buy | $11.00 | |
| 9/11/2023 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $10.00 ➝ $7.00 | |
| 9/8/2023 | William Blair | Initiated Coverage | Outperform | | |
| 8/28/2023 | Piper Sandler | Upgrade | Neutral ➝ Overweight | $9.00 ➝ $12.00 | |
| 6/29/2023 | Guggenheim | Initiated Coverage | Buy | $11.00 | |
| 5/3/2023 | BMO Capital Markets | Lower Target | | $13.00 ➝ $11.00 | |
| 5/3/2023 | UBS Group | Lower Target | | $11.00 ➝ $10.00 | |
| 4/26/2023 | Piper Sandler | Lower Target | | $11.00 ➝ $10.00 | |
| 2/24/2023 | Morgan Stanley | Lower Target | Equal Weight | $11.00 ➝ $10.00 | |
| 11/16/2022 | UBS Group | Lower Target | | $11.00 | |
| 10/21/2022 | Stifel Nicolaus | Downgrade | Buy ➝ Hold | $17.00 ➝ $10.00 | |
| 10/4/2022 | MKM Partners | Initiated Coverage | Neutral | $9.00 | |
| 10/3/2022 | Robert W. Baird | Initiated Coverage | Neutral | $10.00 | |
| 8/12/2022 | Morgan Stanley | Downgrade | Overweight ➝ Equal Weight | $16.00 ➝ $11.00 | |
| 6/27/2022 | The Goldman Sachs Group | Downgrade | Neutral ➝ Sell | $12.00 ➝ $10.00 | |
| 5/13/2022 | BMO Capital Markets | Lower Target | | $23.00 ➝ $18.00 | |
| 5/13/2022 | Piper Sandler | Lower Target | | $18.00 ➝ $13.00 | |
| 3/25/2022 | BMO Capital Markets | Lower Target | | $25.00 ➝ $23.00 | |
| 3/16/2022 | William Blair | Initiated Coverage | Outperform | | |
| 3/11/2022 | Stifel Nicolaus | Upgrade | Hold ➝ Buy | $20.00 | |
| 2/3/2022 | Stifel Nicolaus | Initiated Coverage | Hold | $20.00 | |
| 1/18/2022 | Morgan Stanley | Upgrade | Equal Weight ➝ Overweight | $20.00 | |
| 12/10/2021 | Morgan Stanley | Reiterated Rating | Hold | $19.00 | |
| 11/16/2021 | FIG Partners | Upgrade | Reduce | | |
| 9/17/2021 | UBS Group | Upgrade | Neutral ➝ Buy | $23.00 | |
| 9/17/2021 | Bank of America | Upgrade | Neutral ➝ Buy | $23.00 | |
| 8/17/2021 | Morgan Stanley | Lower Target | Equal Weight | $21.00 ➝ $20.00 | |
| 8/13/2021 | Morgan Stanley | Boost Target | Equal Weight | $20.00 ➝ $21.00 | |
| 7/20/2021 | UBS Group | Initiated Coverage | Neutral | $22.00 | |
| 7/20/2021 | Jefferies Financial Group | Initiated Coverage | Buy | $30.00 | |
| 7/20/2021 | Morgan Stanley | Initiated Coverage | Equal Weight | $20.00 | |
| 7/20/2021 | Wolfe Research | Initiated Coverage | Outperform | $25.00 | |
| 7/20/2021 | Bank of America | Initiated Coverage | Neutral | $23.00 | |
| 7/20/2021 | Piper Sandler | Initiated Coverage | Neutral | $21.00 | |
| 7/20/2021 | The Goldman Sachs Group | Initiated Coverage | Neutral | $23.00 | |
| 7/20/2021 | BMO Capital Markets | Initiated Coverage | Outperform | $25.00 | |